Sirolimus, Rapamune,Rapamycin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 31 USDMF, 4 JDMF, 2 EU WC, 3 KDMF, 22 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

170 Drugs in Development

170 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers, 25 FDA Orange Book, 32 Europe, 2 Canada, 16 Australia, 31 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 8 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 25 BASF, 1 CD Formulation, 11 Corel Pharma Chem, 4 DFE Pharma, 1 Esteem Industries, 2 Finar, 10 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 20 Kerry, 1 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 32 Direct Compression, 28 Granulation, 28 Solubilizers, 26 Thickeners and Stabilizers, 24 Controlled & Modified Release, 22 Disintegrants & Superdisintegrants, 17 Chewable & Orodispersible Aids, 17 Parenteral, 17 Taste Masking, 15 Topical, 14 Film Formers & Plasticizers, 14 Co-Processed Excipients, 12 Lubricants & Glidants, 7 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 3 Rheology Modifiers, 2 Coloring Agents

DIGITAL CONTENT

86 News #PharmaBuzz

86 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 9 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

22 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 3 US Exclusivities, 12 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls

Filters

Sirolimus, Rapamune,Rapamycin

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Seppic

filter Capability Reset all filters

filter Country Reset all filters

01

Seppic

SEPIFILM CLASSIC RANGE

PharmaSynergy

Not Confirmed

02

Seppic

SEPIFILM PW RANGE

PharmaSynergy

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Sirolimus, Rapamune,Rapamycin? Find Coloring Agents used in Sirolimus, Rapamune,Rapamycin to address drug delivery challenges on PharmaCompass.

Sirolimus, Rapamune,Rapamycin

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers

31 USDMF

4 JDMF

2 EU WC

3 KDMF

22 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

170 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers

25 FDA Orange Book

32 Europe

2 Canada

16 Australia

31 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG

TABLET;ORAL - 1MG

TABLET;ORAL - 2MG

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

8 Boai NKY Pharmaceuticals Ltd

4 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 Kirsch Pharma

1 ACG Worldwide

6 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

25 BASF

1 CD Formulation

11 Corel Pharma Chem

4 DFE Pharma

1 Esteem Industries

2 Finar

10 Gangwal Chemicals

4 Ideal Cures

1 Ingredion Pharma Solutions

20 Kerry

1 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

2 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

3 Novo Excipients

3 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

13 Roquette

13 Seppic

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

9 Sigachi Industries

2 Silverline Chemicals

3 The Dow Chemical Company

2 Ulanqab Kema New Material

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons